0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
AI-driven Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-35X12900
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global AI driven Drug Discovery Market Research Report 2023
BUY CHAPTERS

AI-driven Drug Discovery - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-35X12900
Report
September 2024
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

AI-driven Drug Discovery - Market Size

The global market for AI-driven Drug Discovery was estimated to be worth US$ 716 million in 2023 and is forecast to a readjusted size of US$ 1372.6 million by 2030 with a CAGR of 10.5% during the forecast period 2024-2030

AI-driven Drug Discovery - Market

AI-driven Drug Discovery - Market

AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for AI-driven Drug Discovery, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of AI-driven Drug Discovery by region & country, by Type, and by Application.
The AI-driven Drug Discovery market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-driven Drug Discovery.
Market Segmentation

Scope of AI-driven Drug Discovery - Market Report

Report Metric Details
Report Name AI-driven Drug Discovery - Market
Forecasted market size in 2030 US$ 1372.6 million
CAGR 10.5%
Forecasted years 2024 - 2030
Segment by Type:
  • Small Molecule Drug
  • Biological Modeling
  • Structural Biology
  • Others
Segment by Application
  • Pharmaceutical and Biotechnology Companies
  • Research Laboratories
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Entos, Selvita, Benevolent, Exscientia, Euretos, Illumina with AstraZeneca, Novo Nordisk with Microsoft, Iktos, Aqemia, Zephyr AI, Cyclicarx, Eli Lilly, Terray Therapeutics, Ardigen, ReviveMed, Insilico Medicine, XtalPi, MindRank, DP Technology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of AI-driven Drug Discovery manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of AI-driven Drug Discovery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of AI-driven Drug Discovery in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the AI-driven Drug Discovery - Market size in 2030?

Ans: The AI-driven Drug Discovery - Market size in 2030 will be US$ 1372.6 million.

Who are the main players in the AI-driven Drug Discovery - Market report?

Ans: The main players in the AI-driven Drug Discovery - Market are Entos, Selvita, Benevolent, Exscientia, Euretos, Illumina with AstraZeneca, Novo Nordisk with Microsoft, Iktos, Aqemia, Zephyr AI, Cyclicarx, Eli Lilly, Terray Therapeutics, Ardigen, ReviveMed, Insilico Medicine, XtalPi, MindRank, DP Technology

What are the Application segmentation covered in the AI-driven Drug Discovery - Market report?

Ans: The Applications covered in the AI-driven Drug Discovery - Market report are Pharmaceutical and Biotechnology Companies, Research Laboratories

What are the Type segmentation covered in the AI-driven Drug Discovery - Market report?

Ans: The Types covered in the AI-driven Drug Discovery - Market report are Small Molecule Drug, Biological Modeling, Structural Biology, Others

1 Market Overview
1.1 AI-driven Drug Discovery Product Introduction
1.2 Global AI-driven Drug Discovery Market Size Forecast
1.3 AI-driven Drug Discovery Market Trends & Drivers
1.3.1 AI-driven Drug Discovery Industry Trends
1.3.2 AI-driven Drug Discovery Market Drivers & Opportunity
1.3.3 AI-driven Drug Discovery Market Challenges
1.3.4 AI-driven Drug Discovery Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global AI-driven Drug Discovery Players Revenue Ranking (2023)
2.2 Global AI-driven Drug Discovery Revenue by Company (2019-2024)
2.3 Key Companies AI-driven Drug Discovery Manufacturing Base Distribution and Headquarters
2.4 Key Companies AI-driven Drug Discovery Product Offered
2.5 Key Companies Time to Begin Mass Production of AI-driven Drug Discovery
2.6 AI-driven Drug Discovery Market Competitive Analysis
2.6.1 AI-driven Drug Discovery Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by AI-driven Drug Discovery Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Small Molecule Drug
3.1.2 Biological Modeling
3.1.3 Structural Biology
3.1.4 Others
3.2 Global AI-driven Drug Discovery Sales Value by Type
3.2.1 Global AI-driven Drug Discovery Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global AI-driven Drug Discovery Sales Value, by Type (2019-2030)
3.2.3 Global AI-driven Drug Discovery Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical and Biotechnology Companies
4.1.2 Research Laboratories
4.2 Global AI-driven Drug Discovery Sales Value by Application
4.2.1 Global AI-driven Drug Discovery Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global AI-driven Drug Discovery Sales Value, by Application (2019-2030)
4.2.3 Global AI-driven Drug Discovery Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global AI-driven Drug Discovery Sales Value by Region
5.1.1 Global AI-driven Drug Discovery Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global AI-driven Drug Discovery Sales Value by Region (2019-2024)
5.1.3 Global AI-driven Drug Discovery Sales Value by Region (2025-2030)
5.1.4 Global AI-driven Drug Discovery Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America AI-driven Drug Discovery Sales Value, 2019-2030
5.2.2 North America AI-driven Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe AI-driven Drug Discovery Sales Value, 2019-2030
5.3.2 Europe AI-driven Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific AI-driven Drug Discovery Sales Value, 2019-2030
5.4.2 Asia Pacific AI-driven Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America AI-driven Drug Discovery Sales Value, 2019-2030
5.5.2 South America AI-driven Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa AI-driven Drug Discovery Sales Value, 2019-2030
5.6.2 Middle East & Africa AI-driven Drug Discovery Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions AI-driven Drug Discovery Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions AI-driven Drug Discovery Sales Value
6.3 United States
6.3.1 United States AI-driven Drug Discovery Sales Value, 2019-2030
6.3.2 United States AI-driven Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.3.3 United States AI-driven Drug Discovery Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe AI-driven Drug Discovery Sales Value, 2019-2030
6.4.2 Europe AI-driven Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe AI-driven Drug Discovery Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China AI-driven Drug Discovery Sales Value, 2019-2030
6.5.2 China AI-driven Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.5.3 China AI-driven Drug Discovery Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan AI-driven Drug Discovery Sales Value, 2019-2030
6.6.2 Japan AI-driven Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan AI-driven Drug Discovery Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea AI-driven Drug Discovery Sales Value, 2019-2030
6.7.2 South Korea AI-driven Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea AI-driven Drug Discovery Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia AI-driven Drug Discovery Sales Value, 2019-2030
6.8.2 Southeast Asia AI-driven Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia AI-driven Drug Discovery Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India AI-driven Drug Discovery Sales Value, 2019-2030
6.9.2 India AI-driven Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.9.3 India AI-driven Drug Discovery Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Entos
7.1.1 Entos Profile
7.1.2 Entos Main Business
7.1.3 Entos AI-driven Drug Discovery Products, Services and Solutions
7.1.4 Entos AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.1.5 Entos Recent Developments
7.2 Selvita
7.2.1 Selvita Profile
7.2.2 Selvita Main Business
7.2.3 Selvita AI-driven Drug Discovery Products, Services and Solutions
7.2.4 Selvita AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.2.5 Selvita Recent Developments
7.3 Benevolent
7.3.1 Benevolent Profile
7.3.2 Benevolent Main Business
7.3.3 Benevolent AI-driven Drug Discovery Products, Services and Solutions
7.3.4 Benevolent AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.3.5 Exscientia Recent Developments
7.4 Exscientia
7.4.1 Exscientia Profile
7.4.2 Exscientia Main Business
7.4.3 Exscientia AI-driven Drug Discovery Products, Services and Solutions
7.4.4 Exscientia AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.4.5 Exscientia Recent Developments
7.5 Euretos
7.5.1 Euretos Profile
7.5.2 Euretos Main Business
7.5.3 Euretos AI-driven Drug Discovery Products, Services and Solutions
7.5.4 Euretos AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.5.5 Euretos Recent Developments
7.6 Illumina with AstraZeneca
7.6.1 Illumina with AstraZeneca Profile
7.6.2 Illumina with AstraZeneca Main Business
7.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Products, Services and Solutions
7.6.4 Illumina with AstraZeneca AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.6.5 Illumina with AstraZeneca Recent Developments
7.7 Novo Nordisk with Microsoft
7.7.1 Novo Nordisk with Microsoft Profile
7.7.2 Novo Nordisk with Microsoft Main Business
7.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Products, Services and Solutions
7.7.4 Novo Nordisk with Microsoft AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.7.5 Novo Nordisk with Microsoft Recent Developments
7.8 Iktos
7.8.1 Iktos Profile
7.8.2 Iktos Main Business
7.8.3 Iktos AI-driven Drug Discovery Products, Services and Solutions
7.8.4 Iktos AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.8.5 Iktos Recent Developments
7.9 Aqemia
7.9.1 Aqemia Profile
7.9.2 Aqemia Main Business
7.9.3 Aqemia AI-driven Drug Discovery Products, Services and Solutions
7.9.4 Aqemia AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.9.5 Aqemia Recent Developments
7.10 Zephyr AI
7.10.1 Zephyr AI Profile
7.10.2 Zephyr AI Main Business
7.10.3 Zephyr AI AI-driven Drug Discovery Products, Services and Solutions
7.10.4 Zephyr AI AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.10.5 Zephyr AI Recent Developments
7.11 Cyclicarx
7.11.1 Cyclicarx Profile
7.11.2 Cyclicarx Main Business
7.11.3 Cyclicarx AI-driven Drug Discovery Products, Services and Solutions
7.11.4 Cyclicarx AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.11.5 Cyclicarx Recent Developments
7.12 Eli Lilly
7.12.1 Eli Lilly Profile
7.12.2 Eli Lilly Main Business
7.12.3 Eli Lilly AI-driven Drug Discovery Products, Services and Solutions
7.12.4 Eli Lilly AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.12.5 Eli Lilly Recent Developments
7.13 Terray Therapeutics
7.13.1 Terray Therapeutics Profile
7.13.2 Terray Therapeutics Main Business
7.13.3 Terray Therapeutics AI-driven Drug Discovery Products, Services and Solutions
7.13.4 Terray Therapeutics AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.13.5 Terray Therapeutics Recent Developments
7.14 Ardigen
7.14.1 Ardigen Profile
7.14.2 Ardigen Main Business
7.14.3 Ardigen AI-driven Drug Discovery Products, Services and Solutions
7.14.4 Ardigen AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.14.5 Ardigen Recent Developments
7.15 ReviveMed
7.15.1 ReviveMed Profile
7.15.2 ReviveMed Main Business
7.15.3 ReviveMed AI-driven Drug Discovery Products, Services and Solutions
7.15.4 ReviveMed AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.15.5 ReviveMed Recent Developments
7.16 Insilico Medicine
7.16.1 Insilico Medicine Profile
7.16.2 Insilico Medicine Main Business
7.16.3 Insilico Medicine AI-driven Drug Discovery Products, Services and Solutions
7.16.4 Insilico Medicine AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.16.5 Insilico Medicine Recent Developments
7.17 XtalPi
7.17.1 XtalPi Profile
7.17.2 XtalPi Main Business
7.17.3 XtalPi AI-driven Drug Discovery Products, Services and Solutions
7.17.4 XtalPi AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.17.5 XtalPi Recent Developments
7.18 MindRank
7.18.1 MindRank Profile
7.18.2 MindRank Main Business
7.18.3 MindRank AI-driven Drug Discovery Products, Services and Solutions
7.18.4 MindRank AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.18.5 MindRank Recent Developments
7.19 DP Technology
7.19.1 DP Technology Profile
7.19.2 DP Technology Main Business
7.19.3 DP Technology AI-driven Drug Discovery Products, Services and Solutions
7.19.4 DP Technology AI-driven Drug Discovery Revenue (US$ Million) & (2019-2024)
7.19.5 DP Technology Recent Developments
8 Industry Chain Analysis
8.1 AI-driven Drug Discovery Industrial Chain
8.2 AI-driven Drug Discovery Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 AI-driven Drug Discovery Sales Model
8.5.2 Sales Channel
8.5.3 AI-driven Drug Discovery Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. AI-driven Drug Discovery Market Trends
    Table 2. AI-driven Drug Discovery Market Drivers & Opportunity
    Table 3. AI-driven Drug Discovery Market Challenges
    Table 4. AI-driven Drug Discovery Market Restraints
    Table 5. Global AI-driven Drug Discovery Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global AI-driven Drug Discovery Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies AI-driven Drug Discovery Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies AI-driven Drug Discovery Product Type
    Table 9. Key Companies Time to Begin Mass Production of AI-driven Drug Discovery
    Table 10. Global AI-driven Drug Discovery Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global AI-driven Drug Discovery Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global AI-driven Drug Discovery Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global AI-driven Drug Discovery Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global AI-driven Drug Discovery Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global AI-driven Drug Discovery Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global AI-driven Drug Discovery Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global AI-driven Drug Discovery Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global AI-driven Drug Discovery Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global AI-driven Drug Discovery Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global AI-driven Drug Discovery Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global AI-driven Drug Discovery Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global AI-driven Drug Discovery Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global AI-driven Drug Discovery Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global AI-driven Drug Discovery Sales Value by Region (2019-2024) & (%)
    Table 27. Global AI-driven Drug Discovery Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions AI-driven Drug Discovery Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions AI-driven Drug Discovery Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions AI-driven Drug Discovery Sales Value, (2025-2030) & (US$ Million)
    Table 31. Entos Basic Information List
    Table 32. Entos Description and Business Overview
    Table 33. Entos AI-driven Drug Discovery Products, Services and Solutions
    Table 34. Revenue (US$ Million) in AI-driven Drug Discovery Business of Entos (2019-2024)
    Table 35. Entos Recent Developments
    Table 36. Selvita Basic Information List
    Table 37. Selvita Description and Business Overview
    Table 38. Selvita AI-driven Drug Discovery Products, Services and Solutions
    Table 39. Revenue (US$ Million) in AI-driven Drug Discovery Business of Selvita (2019-2024)
    Table 40. Selvita Recent Developments
    Table 41. Benevolent Basic Information List
    Table 42. Benevolent Description and Business Overview
    Table 43. Benevolent AI-driven Drug Discovery Products, Services and Solutions
    Table 44. Revenue (US$ Million) in AI-driven Drug Discovery Business of Benevolent (2019-2024)
    Table 45. Benevolent Recent Developments
    Table 46. Exscientia Basic Information List
    Table 47. Exscientia Description and Business Overview
    Table 48. Exscientia AI-driven Drug Discovery Products, Services and Solutions
    Table 49. Revenue (US$ Million) in AI-driven Drug Discovery Business of Exscientia (2019-2024)
    Table 50. Exscientia Recent Developments
    Table 51. Euretos Basic Information List
    Table 52. Euretos Description and Business Overview
    Table 53. Euretos AI-driven Drug Discovery Products, Services and Solutions
    Table 54. Revenue (US$ Million) in AI-driven Drug Discovery Business of Euretos (2019-2024)
    Table 55. Euretos Recent Developments
    Table 56. Illumina with AstraZeneca Basic Information List
    Table 57. Illumina with AstraZeneca Description and Business Overview
    Table 58. Illumina with AstraZeneca AI-driven Drug Discovery Products, Services and Solutions
    Table 59. Revenue (US$ Million) in AI-driven Drug Discovery Business of Illumina with AstraZeneca (2019-2024)
    Table 60. Illumina with AstraZeneca Recent Developments
    Table 61. Novo Nordisk with Microsoft Basic Information List
    Table 62. Novo Nordisk with Microsoft Description and Business Overview
    Table 63. Novo Nordisk with Microsoft AI-driven Drug Discovery Products, Services and Solutions
    Table 64. Revenue (US$ Million) in AI-driven Drug Discovery Business of Novo Nordisk with Microsoft (2019-2024)
    Table 65. Novo Nordisk with Microsoft Recent Developments
    Table 66. Iktos Basic Information List
    Table 67. Iktos Description and Business Overview
    Table 68. Iktos AI-driven Drug Discovery Products, Services and Solutions
    Table 69. Revenue (US$ Million) in AI-driven Drug Discovery Business of Iktos (2019-2024)
    Table 70. Iktos Recent Developments
    Table 71. Aqemia Basic Information List
    Table 72. Aqemia Description and Business Overview
    Table 73. Aqemia AI-driven Drug Discovery Products, Services and Solutions
    Table 74. Revenue (US$ Million) in AI-driven Drug Discovery Business of Aqemia (2019-2024)
    Table 75. Aqemia Recent Developments
    Table 76. Zephyr AI Basic Information List
    Table 77. Zephyr AI Description and Business Overview
    Table 78. Zephyr AI AI-driven Drug Discovery Products, Services and Solutions
    Table 79. Revenue (US$ Million) in AI-driven Drug Discovery Business of Zephyr AI (2019-2024)
    Table 80. Zephyr AI Recent Developments
    Table 81. Cyclicarx Basic Information List
    Table 82. Cyclicarx Description and Business Overview
    Table 83. Cyclicarx AI-driven Drug Discovery Products, Services and Solutions
    Table 84. Revenue (US$ Million) in AI-driven Drug Discovery Business of Cyclicarx (2019-2024)
    Table 85. Cyclicarx Recent Developments
    Table 86. Eli Lilly Basic Information List
    Table 87. Eli Lilly Description and Business Overview
    Table 88. Eli Lilly AI-driven Drug Discovery Products, Services and Solutions
    Table 89. Revenue (US$ Million) in AI-driven Drug Discovery Business of Eli Lilly (2019-2024)
    Table 90. Eli Lilly Recent Developments
    Table 91. Terray Therapeutics Basic Information List
    Table 92. Terray Therapeutics Description and Business Overview
    Table 93. Terray Therapeutics AI-driven Drug Discovery Products, Services and Solutions
    Table 94. Revenue (US$ Million) in AI-driven Drug Discovery Business of Terray Therapeutics (2019-2024)
    Table 95. Terray Therapeutics Recent Developments
    Table 96. Ardigen Basic Information List
    Table 97. Ardigen Description and Business Overview
    Table 98. Ardigen AI-driven Drug Discovery Products, Services and Solutions
    Table 99. Revenue (US$ Million) in AI-driven Drug Discovery Business of Ardigen (2019-2024)
    Table 100. Ardigen Recent Developments
    Table 101. ReviveMed Basic Information List
    Table 102. ReviveMed Description and Business Overview
    Table 103. ReviveMed AI-driven Drug Discovery Products, Services and Solutions
    Table 104. Revenue (US$ Million) in AI-driven Drug Discovery Business of ReviveMed (2019-2024)
    Table 105. ReviveMed Recent Developments
    Table 106. Insilico Medicine Basic Information List
    Table 107. Insilico Medicine Description and Business Overview
    Table 108. Insilico Medicine AI-driven Drug Discovery Products, Services and Solutions
    Table 109. Revenue (US$ Million) in AI-driven Drug Discovery Business of Insilico Medicine (2019-2024)
    Table 110. Insilico Medicine Recent Developments
    Table 111. XtalPi Basic Information List
    Table 112. XtalPi Description and Business Overview
    Table 113. XtalPi AI-driven Drug Discovery Products, Services and Solutions
    Table 114. Revenue (US$ Million) in AI-driven Drug Discovery Business of XtalPi (2019-2024)
    Table 115. XtalPi Recent Developments
    Table 116. MindRank Basic Information List
    Table 117. MindRank Description and Business Overview
    Table 118. MindRank AI-driven Drug Discovery Products, Services and Solutions
    Table 119. Revenue (US$ Million) in AI-driven Drug Discovery Business of MindRank (2019-2024)
    Table 120. MindRank Recent Developments
    Table 121. DP Technology Basic Information List
    Table 122. DP Technology Description and Business Overview
    Table 123. DP Technology AI-driven Drug Discovery Products, Services and Solutions
    Table 124. Revenue (US$ Million) in AI-driven Drug Discovery Business of DP Technology (2019-2024)
    Table 125. DP Technology Recent Developments
    Table 126. Key Raw Materials Lists
    Table 127. Raw Materials Key Suppliers Lists
    Table 128. AI-driven Drug Discovery Downstream Customers
    Table 129. AI-driven Drug Discovery Distributors List
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
    Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. AI-driven Drug Discovery Product Picture
    Figure 2. Global AI-driven Drug Discovery Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global AI-driven Drug Discovery Sales Value (2019-2030) & (US$ Million)
    Figure 4. AI-driven Drug Discovery Report Years Considered
    Figure 5. Global AI-driven Drug Discovery Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by AI-driven Drug Discovery Revenue in 2023
    Figure 7. AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Small Molecule Drug Picture
    Figure 9. Biological Modeling Picture
    Figure 10. Structural Biology Picture
    Figure 11. Others Picture
    Figure 12. Global AI-driven Drug Discovery Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global AI-driven Drug Discovery Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Pharmaceutical and Biotechnology Companies
    Figure 15. Product Picture of Research Laboratories
    Figure 16. Global AI-driven Drug Discovery Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global AI-driven Drug Discovery Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America AI-driven Drug Discovery Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America AI-driven Drug Discovery Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe AI-driven Drug Discovery Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe AI-driven Drug Discovery Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific AI-driven Drug Discovery Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific AI-driven Drug Discovery Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America AI-driven Drug Discovery Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America AI-driven Drug Discovery Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa AI-driven Drug Discovery Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa AI-driven Drug Discovery Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions AI-driven Drug Discovery Sales Value (%), (2019-2030)
    Figure 29. United States AI-driven Drug Discovery Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States AI-driven Drug Discovery Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States AI-driven Drug Discovery Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe AI-driven Drug Discovery Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe AI-driven Drug Discovery Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe AI-driven Drug Discovery Sales Value by Application (%), 2023 VS 2030
    Figure 35. China AI-driven Drug Discovery Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China AI-driven Drug Discovery Sales Value by Type (%), 2023 VS 2030
    Figure 37. China AI-driven Drug Discovery Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan AI-driven Drug Discovery Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan AI-driven Drug Discovery Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan AI-driven Drug Discovery Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea AI-driven Drug Discovery Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea AI-driven Drug Discovery Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea AI-driven Drug Discovery Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia AI-driven Drug Discovery Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia AI-driven Drug Discovery Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia AI-driven Drug Discovery Sales Value by Application (%), 2023 VS 2030
    Figure 47. India AI-driven Drug Discovery Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India AI-driven Drug Discovery Sales Value by Type (%), 2023 VS 2030
    Figure 49. India AI-driven Drug Discovery Sales Value by Application (%), 2023 VS 2030
    Figure 50. AI-driven Drug Discovery Industrial Chain
    Figure 51. AI-driven Drug Discovery Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmaceutical Labelling Machine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13D10320
Thu Feb 20 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Strip Packaging Machines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36X10626
Thu Feb 20 00:00:00 UTC 2025

Add to Cart

Global Joint Reinforcement Paste Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29I10537
Thu Feb 20 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Coating Devcie Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7E13021
Thu Feb 20 00:00:00 UTC 2025

Add to Cart